SARS News and Research

RSS

Safety and immunogenicity of Moderna vaccines containing mRNA encoding the spike protein of different SARS-CoV-2 strains

Researchers evaluated the safety and immunogenicity of COVID-19 vaccines against SARS-CoV-2 variants of concern.

20 Jul 2022

Fatigue in long covid patients linked to anxiety, depression, and apathy

The most common symptoms of the post-COVID-19 condition known aslong covidinclude fatigue, shortness of breath and cognitive dysfunction, according to the World Health Organization (WHO).

20 Jul 2022

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Researchers compared the levels of cross-reactive neutralizing antibodies elicited by SARS-CoV-2 Omicron BA.4 and BA.1 infections.

20 Jul 2022

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Researchers assessed the association between natural killer cell dysfunction and COVID-19 disease severity.

20 Jul 2022

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.

20 Jul 2022

Scientists find new evidence against using BET inhibitors to treat COVID-19

A while ago, some researchers had suggested that blocking a set of proteins, known as bromodomain and extraterminal (BET) proteins, might be a way to fight COVID-19.

20 Jul 2022

Adolescents are more likely than older adults to get COVID

At the beginning of the pandemic, there was a general perception that children and teenagers were much less likely to get COVID-19 than adults. It was fueled by early data from across the globe that found very low rates of COVID in adolescents (defined as ages 10-19) and youth (15-24). But the data was mixed and some questioned its validity.

20 Jul 2022

Potential mRNA vaccines for influenza

Scientists discuss the benefits of shifting the global influenza vaccination system to a mRNA-based platform,

19 Jul 2022

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

19 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

A new study has pointed out that Molnupiravir treatment increases the ratio of transition to transversion mutations in COVID-19 patients and that the treatment does not appear to induce resistance mutations in the SARS-CoV-2 genome.

19 Jul 2022

Researchers discover new key protection against COVID-19 in saliva

The novel coronavirus (SARS-CoV-2) has spread around the world at an unprecedented rate, evading containment countermeasures.

19 Jul 2022

What is the impact of SARS-CoV-2 variant booster vaccinations?

Researchers conducted preliminary assessments of a booster vaccination with the SARS-CoV-2 variant vaccines.

19 Jul 2022

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Researchers reviewed the consequences of infection with sSARS-CoVs on the host DNA damage response.

19 Jul 2022

Influence of chr12q24.13 domain on COVID-19 severity

Researchers evaluated the probable impact of the chr12q24.13 domain on the outcomes of laboratory-validated SARS-CoV-2 infection.

19 Jul 2022

Scientists explore guanine-specific pocket in SARS-CoV-2 nucleocapsid protein of therapeutic value against multiple coronaviruses

Researchers studied open and closed conformations of the C-terminal of SARS-CoV-2 nucleocapsid (N) protein termed the NCTD.

19 Jul 2022

What were the drivers of influenza decline during the COVID-19 pandemic?

Researchers investigated the potential drivers of a global decline in influenza virus circulation during the COVID-19 pandemic.

19 Jul 2022

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Investigators examined the effectiveness of two, three, and four SARS-CoV-2 vaccine doses during the Omicron prevalent phases.

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

SARS News and Research

Safety and immunogenicity of Moderna vaccines containing mRNA encoding the spike protein of different SARS-CoV-2 strains

Fatigue in long covid patients linked to anxiety, depression, and apathy

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Scientists find new evidence against using BET inhibitors to treat COVID-19

Adolescents are more likely than older adults to get COVID

Potential mRNA vaccines for influenza

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

Researchers discover new key protection against COVID-19 in saliva

What is the impact of SARS-CoV-2 variant booster vaccinations?

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Influence of chr12q24.13 domain on COVID-19 severity

Scientists explore guanine-specific pocket in SARS-CoV-2 nucleocapsid protein of therapeutic value against multiple coronaviruses

What were the drivers of influenza decline during the COVID-19 pandemic?

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Should siRNA-based antivirals be added to the COVID toolbox?

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News